Cafepharma Today

May 16 2025 - Novo CEO to depart as obesity drugmaker’s challenges rise
Novo CEO to depart as obesity drugmaker’s challenges rise
BioMarin expands enzyme expertise with $270M Inozyme buy
Amgen could owe Regeneron more than $400M after defeat in cholesterol drug antitrust suit
Eli Lilly collaborates with Rznomics on hearing loss treatment in $1.3 billion pact
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Drug stocks slump with broader market
MarketWatch
Saturday, May 8, 2010 - 10:04am
tags:
drug stocks
Drug Companies: Recession-Resistant, but Government-Proof?
Motley Fool
Saturday, May 8, 2010 - 10:03am
tags:
investors
Glaxo Plans Two `Small' Deals; Competition Pushes Up Price of Acquisitions
Bloomberg
Friday, May 7, 2010 - 11:53am
tags:
GSK, M&A, Andrew Witty
$1B in cash grants available soon for small biotech
Fierce Biotech
Friday, May 7, 2010 - 9:16am
tags:
biotech, grants
Warner Chilcott reports 1Q loss, big revenue leap
Yahoo/AP
Friday, May 7, 2010 - 9:15am
tags:
Warner Chilcott, earnings
Arena pares 1Q loss as research spending falls
Yahoo/AP
Friday, May 7, 2010 - 9:14am
tags:
Arena Pharmaceuticals, earnings
FDA to review Amylin, Lilly diabetes drug
Reuters
Friday, May 7, 2010 - 8:35am
tags:
FDA, Eli Lilly, Amylin, Byetta, diabetes
Live From BIO: The future of pharma growth
Fierce Biotech
Friday, May 7, 2010 - 8:34am
tags:
BIO, pharma industry, biotech, generics, emerging markets
Drugmakers Lose Hepatitis C Trial
Pharmalot
Friday, May 7, 2010 - 8:31am
tags:
hepatitis C, Teva Pharmaceuticals, Baxter International
Halozyme posts smaller 1Q loss as costs fall
Yahoo/AP
Friday, May 7, 2010 - 8:29am
tags:
earnings, Halozyme
More US doctors closing the door on pharma sales reps
Pharma Times, UK
Friday, May 7, 2010 - 7:55am
tags:
physician access
Alexion Pharmaceuticals: Warming Up or Cooling Off?
Motley Fool
Friday, May 7, 2010 - 7:53am
tags:
Alexion
Bayer Wins U.S. Approval of New Type of Contraceptive
Bloomberg
Friday, May 7, 2010 - 7:51am
tags:
Bayer, FDA, contraceptives, birth control pill, Natazia
Intellipharmaceutics plans Effexor generic
Yahoo/AP
Friday, May 7, 2010 - 7:50am
tags:
Effexor, Pfizer, generics, Intellipharmaceutics
Lilly to cut 200 sales, marketing support jobs
Indianapolis Star, IN
Friday, May 7, 2010 - 6:38am
tags:
Eli Lilly, layoffs
Sequenom 1Q loss widens on costs, margins
Yahoo/AP
Friday, May 7, 2010 - 6:35am
tags:
Sequenom, earnings
Good Deal Now, Bad Deal Later: It's a Biotech Thing
Motley Fool
Friday, May 7, 2010 - 6:28am
tags:
Ariad Pharmaceuticals, Merck, Novartis, Abbott Laboratories, ridaforolimus
Now There’s Pig Virus DNA in Merck’s Rotavirus Vaccine, Too
WSJ Online
Friday, May 7, 2010 - 6:27am
tags:
Merck, vaccines, rotavirus, GSK, Rotarix, RotaTeq
Drugmaker Shuns Blockbuster Route To Find The Right Niches
Investors.com
Friday, May 7, 2010 - 6:23am
tags:
Valeant Pharmaceuticals
Connecticut Bill To Limit Gifts To Docs Dies Quietly
Pharmalot
Thursday, May 6, 2010 - 4:11pm
tags:
physician gifts, Connecticut

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.